Available reports suggest that, Leishmania donovani antigen KMP-11 may be significant in the modulation of immune responses in visceral leishmaniasis (VL). This study evaluated vaccine prospect of presentation of KMP-11 antigen through murine dendritic cells against VL in infected BALB/c mice. We report here that immunization with KMP-11 delivered through bone marrow derived dendritic cells can lead to killing of L. donovani in infected BALB/c mice. Furthermore, the strategy to use KMP-11 as vaccine delivered through DCs can stimulate the production of IFN-γ, IL-12, IL-2R and TNF-α with concomitant down-regulation of IL-10 and IL-4. Furthermore, anti-leishmanial defence function (ROS) of splenocytes was observed increased in the presence of DC-delivered KMP-11 vaccination accompanied with an increased p38-MAPK signalling in vaccinated splenocytes. We summarized from our data that KMP-11 delivered through DCs has potential for eliciting protective immunity through pro-inflammatory cytokines (IFN-γ, IL-12, IL-2, TNF-α) following an up-regulation in signalling event of p38-MAPK. Therefore the study suggests a new control strategy against VL in future.
Introduction
Leishmania, a protozoan pathogen, is a causative agent of various forms of Infection of Leishmania parasite in dendritic cells has been reported in several studies [5] [6] . Antigen presenting cells (APCs) help in establishment of immunological memory as well as induction of a primary immune response [7] . In the light of these findings, it appears that macrophages through the preferred host for Leishmania may synergise with Leishmania to facilitate infection [8] [9] and as such secreting dendritic cells for parasite delivery to provoke host protective immune response is necessity.
The outer membrane of Leishmania is covered by a dense glycocalyx consisting mostly lipophosphoglycan (LPG) [10] . Kinetoplastid Membrane Protein 11 (KMP-11) is a major surface protein of L. donovani species which remains non-covalently attached with LPG [11] . KMP-11 plays important role in reversal of T-cell anergy and synthesis of interleukin-12 as well as up-regulation of inducible nitric oxide synthase (iNOS) in animal model [12] [13] . We reported earlier, immunomodulation in monocyte derived dendritic cells leads to induction of IFN-γ by rLdKMP-11 antigen [14] . Modern Research in Inflammation Flow Cytometry. DCs were positive for CD86 and DEC 205.
Effect of Doses and Concentration of Immunogen for Tolerance of Splenocytes in BALB/c Mice
Briefly, splenocytes were subjected to immunogen at 3 different concentrations (5, 10 & 20 µg/mL) for 48 h incubation followed by RPMI-MTT treatment (1 mg/mL) at 37˚C for 3 h then it was kept in isopropanolic solution for another 15 min and finally absorbance was taken at 570 nm [16] .
Detection of Anti-KMP-11 Antibody in VL Patients
The recombinant KMP-11 protein was obtained as described previously [14] .
Serum samples were pooled from 10 treated VL patients (3 ml each). Then serum (0.1 ml) was mixed with 0.1 ml of 6% polyethylene glycol (PEG) in PBS and incubated for 1h at 4˚C. Mixtures were centrifuged at 1000 g for 60 minutes at 4˚C and the pellet was washed twice in a final concentration of 3% PEG and resuspended this pellet in 0.1 ml PBS. Now this resuspended pellet in PBS were run on SDS-PAGE (12.5%) by following Laemmli method [17] , transferred this gel onto NCP membrane (Sigma, USA) using trans blotting chamber at 50 V for 1 h then at 100 V for 1 h. This membrane were kept overnight at 4˚C in blocking buffer (5% BSA in Tris-buffered saline) then washed 3× TBS-T (0.1% tween), number of parasites present in the spleen was determined by microscopic evaluation of Giemsa-stained tissue imprints as described previously [19] . The parasite burden in the respective organs was expressed as LDU [20] .
Determination of Live Parasite Burden
Briefly, a weighed portion of spleen from different groups of experimental mice 60 days after infection was dissected out and mildly homogenized in complete medium 199 (M199, Sigma USA) and re-suspended at a final concentration of 1 mg/mL in the same medium. Cells were washed, fixed in methanol and giemsa stained for enumeration and expression of parasite load as amastigotes/100 macrophage. To further determine the efficacy of DC-primed KMP-11 as vaccine, splenocytes were washed and stained with popidium iodide (PI) for FACS determination of percentage of killing in different groups of animals. The mean of fluorescence intensity of the cells were analyzed by flow cytometry FACS Calibur and CellQuest software.
Assessment of T-Cell Proliferation
Proliferation of splenocytes isolated on day 60 after infection from the infected groups of mice (n = 10) was measured in response to KMP-11 (10 µg/mL). Briefly, single cell suspensions of splenocytes were plated at a concentration of 0.1 × 10 6 cells in 96 well plates and were allowed to proliferate for 3 days at 37˚C in a 5% CO 2 incubator in the presence or absence of KMP-11 antigen (10 µg/mL). Cell proliferation was determined by BrdU (5-bromo-2' deoxyuridine) incorporation on FACS Calibur. Soluble leishmania antigen (SLA) was used as control.
Analysis of Th1 and Th2 Cytokines
Subsequent experiments were performed to look at the potential of vaccination to drive CD4 T-cell cytokine response in splenocytes of vaccinated mice. Splenocytes were isolated by density gradient centrifugation over Ficoll-Paque (Pharmacia, Uppsala, Sweden). Cells (2 × 10 6 /mL) were cultured in 12-well plates for 24 h with purified L. donovani protein (KMP-11). The culture conditions involved humidified 5% CO 2 incubation at 35˚C ± 1˚C, 6 h prior to completion of incubation, the plate was supplemented with monensin containing golgi stop (2 µM/mL final concentration, Pharmingen). The cells were then harvested using ice-cold PBS plus azide, cytofixed using 2% formaldehyde. The cells were then permeabilized with a solution of saponin and stained for 30 min using antimouse cytokine antibodies directly conjugated with FITC (IFN-γ, IL-12 & IL-2R), APC (IL-4 and IL-10). PE and FITC labeled immunoglobulin control antibodies as well as a control of unstimulated peripheral blood mononuclear cells (PBMCs) were included in these experiments. The cells were acquired and analyzed within 24 h through FACS Calibur (Flow Cytometer, Becton Dickinson, USA) [21] . The results were analyzed by using BD Cell Quest software (Becton Dickinson, USA).
Comparison of Anti-Leishmanial Macrophage Function in Un-Immunized and Immunized Group of Mice
Measurements of reactive oxygen species (ROS) activity in splenocytes were accomplished with flow cytometry. Briefly, 100 µL of splenocyte blood was triggered with N-Formylmethionine-leucyl-phenylalanine (FMLP; 5 mg/mL) at 37˚C in a water bath for 10 min, followed by further incubation with 20 µL of 10 mm dihydrorhodamine-123 (DHR-123) at 37˚C in a water bath for 15 min to allow for the internalization of the later into the cell and converted into green 
Statistical Analysis
All data were expressed as mean ± SE (standard error of the mean). One way analysis of variance with Tukey post-hoc test was carried out using Graph Pad Prism 5, USA software. A value of significance p < 0.05 was considered statistically significant.
Results

Dendritic Cells Generation from Bone Marrow of BALB/c Mice
DCs from bone marrow of BALB/c mice were obtained as described earlier. 
Effect of Doses and Concentration of Immunogen on BALB/c Mice
It was observed that 10 µg/ml KMP-11 given with 1 × 10 6 DC resulted in highest viability of splenocytes (Table 1) .
KMP-11 Is Naturally Immunogenic in VL Patients which Possesses Abilities to Overcome Impaired T-Cell Proliferation Associated with VL
The presence of antibodies (1:500 & 1:1000) against KMP-11 in successful treated VL patients sera was detected in western blot analysis with purified protein. We found that treated VL patients sera had antibody against KMP-11 antigen ( Figure 2 ). These findings suggest that KMP-11 antigen is immunogenic in VL patients and hence observed to be appropriate for vaccine testing in animals.
The Ability of DC-Primed KMP-11 Vaccination in Protection against Virulent L. donovani
DC primed rKMP-11 immunization protects against VL. DC primed KMP-11
immunized animals were challenged with L. donovani and no. of intracellular parasites were compared on day 60 post infection in spleen from different groups of animals ( Figure 3(a) ). We observed that following SLA immunization, the splenic percent killing were reduced by 82.5% whereas DC-primed KMP-11 immunization reduced 90.58% parasites from spleen (Table 2) . Splenocytes staining with propidium iodide and subsequent FACS data corroborated the preceding finding, ensuring that considerable degree of protection was afforded after DC immunization (Figure 3(b) ). 
Dendritic Cells Primed KMP-11 Immunization Reverts Dysfunction of T-Cells Proliferation in Infected BALB/c Mice
We observed enhanced T-cell proliferation from splenocytes in response to 
Evaluation of Ability of Vaccine to Trigger Th1 and Th2 Response in Immunized Mice
As functionally more splenocytes proliferated upon antigenic re-stimulation to KMP-11 antigen, we further extended our investigation to understand nature of immune response generated by vaccination. A total of 10 mice each was tested for this investigation from different study group. As shown in Figures 5(a) - ( 
Vaccination with DC-KMP Promoted ROS Production in Macrophages Which Is p38MAP Kinase
Because reactive oxygen species are important leishmanicidal molecules, we 
Discussion
This study gives a new vaccine strategy of dendritic cell presented KMP-11 as immunogen for control against experimental VL. It was also apparent that KMP-11 antigen promoted the activation of DCs in particular compared to L. donovani infected mice that produced IL-12.
LPG linked KMP-11 is the major protein on the promastigote surface which plays a key role in immunity against L. donovani We also investigated about KMP-11 mediated alteration in signaling pathways that result in the production of pro-inflammatory cytokines such as IL-12. We have shown that the effector response in form of ROS and IL-12 was mainly because following priming DCs with KMP-11, the defective p38MAPK was restored in splenocytes. The p38MAPK inhibition increased parasite load, but impaired ROS production and IL-2 secretion. In conclusion, we report a new vaccine approach for control against VL.
